Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE)
NCT02101151
Avitaminosis, Body Weight
Ajman, United Arab Emirates
View Trial DetailsNCT Number: NCT00695474
The purpose of the study is to describe vitamin D status among patients with type 2 diabetes and to determine the association between serum 25-hydroxyvitamin D and glycemic control, markers of inflammation and blood pressure
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
It has been estimated that 1 billion people worldwide have vitamin D deficiency or insufficiency. It is well known that vitamin D deficiency causes osteoporosis, increases the risk of fracture and causes muscle weakness. But there is now evidence that calcium malnutrition and hypovitaminosis D are predisposing conditions for various common chronic diseases such as malignancies (particularly colon, breast and prostate) chronic inflammatory and autoimmune disease (inflammatory bowel disease, multiple sclerosis) as well as metabolic disorders (metabolic syndrome, hypertension).
It has also been reported that vitamin D deficiency may predispose to glucose intolerance, altered insulin secretion and type 2 diabetes mellitus.
The purpose of this study is to determine vitamin D status among type 2 diabetics in our outpatient clinic and examine the relationship between vitamin D status , calcium and phosphorous metabolism, inflammatory markers, glycemic control, blood pressure and lipid profile.
Moreover the patients are asked to answer a questionnaire regarding lifestyle, exercise, sun exposure and food intake.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: December 08
Time frame: December 08
University of Aarhus
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02101151
Avitaminosis, Body Weight
Ajman, United Arab Emirates
View Trial DetailsNCT06115356
Avitaminosis, Body Weight
Trieste, Italy
View Trial DetailsNCT06551688
Avitaminosis, Breast Diseases
El Fayoum Qesm, Faiyum Governorate, Egypt
View Trial DetailsNCT04556136
Avitaminosis, Deficiency Diseases
Tacoma, Washington, United States
View Trial Details